Intervention not reported
Health‐related quality of life · participants with relapsed or recurrent CTEV
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Findings
What do systematic reviews say?
6 questions · 6 findings · 2 reviews · Neuromuscular
No studies found 4 · 66.7%GRADE not reported 1 · 16.7%Very low 0 · 0%Low 0 · 0%Moderate 1 · 16.7%High 0 · 0%
Intervention not reported
Health‐related quality of life · participants with neglected CTEV
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Intervention not reported
Health‐related quality of life · participants with CTEV (type of case (i.e. whether initial presentation or relapsed) not specified)
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Intervention not reported
Health‐related quality of life · participants with CTEV at initial presentation
1 finding from 1 review
- no estimate extracted2 studies · 2 participantsGRADE not reported
Intervention not reported
Health‐related quality of life · participants with resistant CTEV
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Intervention not reported
Health‐related quality of life Short Form 12 Health Survey (SF‐12) · people with ALS/MND
1 finding from 1 review
- Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease 2017 · Cochrane Headline outcomes onlyno estimate extracted1 study · 128 participantsModerate